Fanjun Cheng
Impact in
-
- Mesenchymal stem cell research
- Chronic Lymphocytic Leukemia Research
-
- Chronic Myeloid Leukemia Treatments
Papers in
- Hematology 11
- Chronic Myeloid Leukemia Treatments 7
- Acute Myeloid Leukemia Research 4
- Genetics 10
- Chronic Lymphocytic Leukemia Research 6
- Mesenchymal stem cell research 4
- Co-authors
- Xiaojian Zhu (6 shared papers)Na Jin (1 shared paper)Ping Zou (7 shared papers)Liling Zhang (1 shared paper)Zhaodong Zhong (6 shared papers)Yong You (6 shared papers)Weilong Chang (1 shared paper)An‐Yuan Guo (4 shared papers)
- Journals
- Scientific Reports (2 papers)Biochemical and Biophysical Research Communications (1 paper)Journal of Cellular Biochemistry (1 paper)Cancer Research (1 paper)Immunopharmacology and Immunotoxicology (1 paper)
- Partner nations
- China
In The Last Decade
Fanjun Cheng
25 papers receiving 319 citations
Peers
Comparison fields: 5 of 66
- Genetics 59
- Hematology 58
- Cancer Research 57
- Oncology 88
- Molecular Biology 144
Countries citing papers authored by Fanjun Cheng
This map shows the geographic impact of Fanjun Cheng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fanjun Cheng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fanjun Cheng more than expected).
Fields of papers citing papers by Fanjun Cheng
This network shows the impact of papers produced by Fanjun Cheng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fanjun Cheng. The network helps show where Fanjun Cheng may publish in the future.
Co-authors
The 25 scholars most cited alongside Fanjun Cheng, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 26 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 83 | |
| 2 | 2016 | 49 | |
| 3 | 2018 | 42 | |
| 4 | 2010 | 31 | |
| 5 | 2008 | 18 | |
| 6 | 2021 | 13 | |
| 7 | 2022 | 10 | |
| 8 | 2014 | 10 | |
| 9 | 2019 | 9 | |
| 10 | 2019 | 9 | |
| 11 | 2019 | 9 | |
| 12 | 2016 | 6 | |
| 13 | [The growth characteristics of mesenchymal stem/progenitor cells in human umbilical cord blood]. | 2003 | 6 |
| 14 | 2023 | 5 | |
| 15 | 2010 | 4 | |
| 16 | 2020 | 3 | |
| 17 | [The effect of recombinant human erythropoietin on the migration of bone marrow derived mesenchymal stem cells in vitro]. | 2008 | 3 |
| 18 | 2021 | 2 | |
| 19 | [Analysis of essential oil from Amomum tsaoko by extraction of supercritical CO2 fluid]. | 2000 | 2 |
| 20 | 2019 | 2 |
About Fanjun Cheng
Fanjun Cheng is a scholar working on Hematology, Genetics, Molecular Biology, Oncology and Cancer Research, having authored 26 papers that have together received 322 indexed citations. Recurring topics across this work include Chronic Myeloid Leukemia Treatments (7 papers), Chronic Lymphocytic Leukemia Research (6 papers), Acute Myeloid Leukemia Research (4 papers), Mesenchymal stem cell research (4 papers), HER2/EGFR in Cancer Research (3 papers), Retinoids in leukemia and cellular processes (2 papers), Cancer Cells and Metastasis (2 papers) and Pharmacological Effects of Natural Compounds (2 papers). The work is most often cited by research in Genetics (59 citations), Hematology (58 citations), Cancer Research (57 citations), Oncology (88 citations) and Molecular Biology (144 citations). Fanjun Cheng has collaborated with scholars based in China. Frequent co-authors include Xiaojian Zhu, Na Jin, Ping Zou, Liling Zhang, Zhaodong Zhong, Yong You, Weilong Chang, An‐Yuan Guo, Bin Fang and Wei Liu. Their work appears in journals such as Scientific Reports, Biochemical and Biophysical Research Communications, Journal of Cellular Biochemistry, Cancer Research and Immunopharmacology and Immunotoxicology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.